Cargando…
Pathophysiological Implications of Imbalances in Fibroblast Growth Factor 23 in the Development of Diabetes
Observational studies have associated the increase in fibroblast growth factor (FGF) 23 levels, the main regulator of phosphate levels, with the onset of diabetes. These studies open the debate on the plausible existence of undescribed diabetogenic mechanisms derived from chronic supraphysiological...
Autores principales: | Donate-Correa, Javier, Martín-Núñez, Ernesto, González-Luis, Ainhoa, Ferri, Carla M., Luis-Rodríguez, Desirée, Tagua, Víctor G., Mora-Fernández, Carmen, Navarro-González, Juan F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230948/ https://www.ncbi.nlm.nih.gov/pubmed/34208131 http://dx.doi.org/10.3390/jcm10122583 |
Ejemplares similares
-
Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications
por: Donate-Correa, Javier, et al.
Publicado: (2021) -
Inflammatory Targets in Diabetic Nephropathy
por: Donate-Correa, Javier, et al.
Publicado: (2020) -
Fibroblast growth factor 23 expression in human calcified vascular tissues
por: Donate-Correa, Javier, et al.
Publicado: (2019) -
Repurposing drugs for highly prevalent diseases: pentoxifylline, an old drug and a new opportunity for diabetic kidney disease
por: Donate-Correa, Javier, et al.
Publicado: (2022) -
Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease
por: Donate-Correa, Javier, et al.
Publicado: (2021)